RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAUE36DDC340E894E1A

https://w3id.org/ripe/ripe-kg/author/RIPEAUE36DDC340E894E1A
SubjectPredicateObject
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type node1
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type rdfs:Resource
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type owl:Thing
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type prov:Person
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type foaf:Person
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy owl:sameAs https://semopenalex.org/author/A5113708764
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy http://www.w3.org/ns/org#memberOf ripekg:organization/RIPEO145587F53CDF417BDepartment of Nutrition
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy foaf:familyName Goodarzy
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy foaf:givenName Sima
ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy foaf:name Sima Goodarzy
ripekg:work/10.1111%2F1756-185x.13688Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial dcterms:creator ripekg:author/RIPEAUE36DDC340E894E1ASima Goodarzy